Financial Toxicity in People With Inflammatory Bowel Disease

Richard S Bloomfeld; Stephen J Bickston

doi:10.1093/ibd/izaa267

Financial Toxicity in People With Inflammatory Bowel Disease

Inflamm Bowel Dis. 2021 Jun 15;27(7):1170-1171. doi: 10.1093/ibd/izaa267.

Authors

Richard S Bloomfeld¹, Stephen J Bickston²

Affiliations

¹ Section of Gastroenterology, Wake Forest Univeristy School of Medicine, Winston Salem, NC, USA.
² Virginia Commonwealth University Health Center, Richmond, VA, USA.

PMID: 33146376
DOI: 10.1093/ibd/izaa267

Abstract

Financial toxicity is the term for problems our patients suffer related to the cost of medical care. It differs from both direct and indirect costs and is surprisingly common in patients that most would consider well-insured. This editorial discusses steps we can take to limit our patients' suffering.

Keywords: epidemiology; financial toxicity; quality of life.

Publication types

Editorial

MeSH terms

Chronic Disease
Cost of Illness*
Financial Stress*
Health Expenditures
Humans
Inflammatory Bowel Diseases* / economics